JENBURKT PHARMACEUTICALS LTD. - Board to consider Dividend

Jenburkt Pharmaceuticals Ltd has informed BSE that a Meeting of Board of Directors of the Company is scheduled to be held on May 30, 2016, inter alia, to consider:<BR><BR>1. To take on record the audited results for the quarter / financial year ended on March 31, 2016.<BR><BR>2. To recommend Dividend, if any.